Dr. Scott received his PhD on leukemia epigenetics at the University of Saskatchewan, Canada, under the mentorship of Dr. John DeCoteau. In 2005, he then joined the American Board of Medical Genetics (ABMG) postdoctoral clinical molecular genetics training program at Mount Sinai School of Medicine and was certified in 2007. Dr. Scott then received additional laboratory training in cytogenetics, which lead to his second ABMG certification in clinical cytogenetics in 2009. In addition to clinical molecular genetics, cytogenetics, and epigenetics, Dr. Scott’s research interests also include the field of pharmacogenetics and studying the role of heritable genetic variation in drug response.